The pricey and potential life-or-death issue lingers after the majority of the 600.

Cardiologists question FDA tips about genetic testing before taking Plavix Which antiplatelet medication is best after a coronary stent? The pricey and potential life-or-death issue lingers after the majority of the 600, 000 angioplasties performed every full year in the usa. The response may lie in your genes, but professional cardiovascular societies and several working cardiologists issue the U.S. Meals and Drug Administration's recent recommendation that patients undergo genetic tests before taking Plavix . MULTIMEDIA ALERT: Sound bites of an interview with Dr. Pereira, research principal investigator, can be found on the Mayo Clinic News Network. The Tailored Antiplatelet Therapy to reduce Outcomes after Percutaneous Coronary Intervention Study, launched this summer by the Center for Individualized Medicine and the Division of Cardiovascular Diseases at Mayo Clinic, examines whether prescribing heart medicine based on a patient's CYP2C19 genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in individuals who undergo percutaneous coronary intervention, called angioplasty commonly.The radioactivity levels produced by the arsenic are much like those used in standard, routine imaging methods in humans. The technique allowed them to find and capture clear images of the tumors unusually. They also discovered that there was little if any detectable uptake of bavituximab by normal organs, including the liver, a common site where drugs become entrapped. Thorpe. Several radionuclides are found in imaging currently, but many of the isotopes decay, or breakdown, before they reach the prospective in the body. The slow rate of decay of arsenic isotopes, together with their stable chemistry, allowed the researchers to few arsenic to bavituximab and acquire pictures of the tumors for several days following the drug was given.

Other entries from category "immunology":

Random entries